$1.30
0.032.36%
After Hours: Jun 20, 7:30 PM EDT
Comments
Loading...
Enveric Biosciences Analyst Ratings and Price Targets | NASDAQ:ENVB | Benzinga
Enveric Biosciences Inc has a consensus price target of $10 based on the ratings of 1 analysts. The high is $10 issued by HC Wainwright & Co. on March 6, 2025. The low is $10 issued by HC Wainwright & Co. on March 6, 2025. The 2 most-recent analyst ratings were released by HC Wainwright & Co. on March 6, 2025 and January 30, 2024, respectively. With an average price target of $10 between HC Wainwright & Co., there's an implied 669.23% upside for Enveric Biosciences Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
1calculated from analyst ratings
Analyst Ratings for Enveric Biosciences
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/06/2025 | Buy Now | 669.23% | HC Wainwright & Co. | Vernon Bernardino49% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 01/30/2024 | Buy Now | 669.23% | HC Wainwright & Co. | Vernon Bernardino49% | → $10 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Enveric Biosciences (ENVB) stock?
The latest price target for Enveric Biosciences (NASDAQ:ENVB) was reported by HC Wainwright & Co. on March 6, 2025. The analyst firm set a price target for $10.00 expecting ENVB to rise to within 12 months (a possible 669.23% upside). 1 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Enveric Biosciences (ENVB)?
The latest analyst rating for Enveric Biosciences (NASDAQ:ENVB) was provided by HC Wainwright & Co., and Enveric Biosciences reiterated their buy rating.
When was the last upgrade for Enveric Biosciences (ENVB)?
There is no last upgrade for Enveric Biosciences
When was the last downgrade for Enveric Biosciences (ENVB)?
There is no last downgrade for Enveric Biosciences.
When is the next analyst rating going to be posted or updated for Enveric Biosciences (ENVB)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Enveric Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Enveric Biosciences was filed on March 6, 2025 so you should expect the next rating to be made available sometime around March 6, 2026.
Is the Analyst Rating Enveric Biosciences (ENVB) correct?
While ratings are subjective and will change, the latest Enveric Biosciences (ENVB) rating was a reiterated with a price target of $10.00 to $10.00. The current price Enveric Biosciences (ENVB) is trading at is $1.30, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
